Proposed Collection; 60-Day Comment Request; Application for Collaboration With the Therapeutic Development Branch (TDB), Division of Preclinical Innovation (DPI), National Center for Advancing Translational Sciences (NCATS), 69499-69500 [2014-27636]

Download as PDF Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Chapter RV—HIV/AIDS Bureau Health Resources and Services Administration Delete the functions for the Division of HIV/AIDS Training and Capacity Development (RV7) within the HIV/ AIDS Bureau (RV) and replace in its entirety. Section RV–20, Functions Statement of Organization, Functions and Delegations of Authority This notice amends Part R of the Statement of Organization, Functions and Delegations of Authority of the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 79 FR 63412–63414 dated October 23, 2014). This notice reflects organizational changes in the Health Resources and Services Administration (HRSA). Specifically, this notice abolishes the Division of Global Training and Development and transfers the Global Health Workforce Training Programs from the Bureau of Health Workforce (RQ) to the HIV/AIDS Bureau (RV). Chapter RQ—Bureau of Health Workforce Section RQ–20, Functions Delete the functions for the Office of Global Health Affairs (RQA1) within the Bureau of Health Workforce (RQ) and replace in its entirety. mstockstill on DSK4VPTVN1PROD with NOTICES Office of Global Health Affairs (RQA1) The Office of Global Health Affairs serves as the principal advisor to the Office of Workforce Development and Analysis Director and the Associate Administrator on global health issues. Specifically: (1) Provides leadership, coordination, and advancement of global health activities relating to health care services for vulnerable and at-risk populations and for HRSA training programs; (2) provides support for the agency’s International Visitors Program; (3) develops linkages and facilitates a mutual exchange of expertise for domestic and international programs aimed at improving quality and innovation in health professions education, retention, training, faculty development and community based systems of care; (4) provides leadership within HRSA for the support of global health and coordinates policy development with the HHS Office of Global Health Affairs and other departmental agencies, and; (5) supports and conducts programs with respect to activities associated with the international migration, domestic training, and utilization of foreign medical graduates and U.S. citizens studying abroad. VerDate Sep<11>2014 18:00 Nov 20, 2014 Jkt 235001 Division of HIV/AIDS Training and Capacity Development (RV7) The Division of HIV/AIDS Training and Capacity Development provides national leadership and manages the implementation of Part F under Title XXVI of the PHS Act as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009, P.L. 111–87 (the Ryan White HIV/AIDS Program), including the Special Projects of National Significance and the AIDS Education and Training Centers Programs. The Special Projects of National Significance Program develops innovative models of HIV care and the AIDS Education and Training Centers Program increases the number of health care providers who are educated and motivated to counsel, diagnose, treat, and medically manage people with HIV disease and to help prevent high-risk behaviors that lead to HIV transmission. The division also implements the training and systems strengthening functions of the Global HIV/AIDS Program as part of the President’s Emergency Plan for AIDS Relief (PEPFAR). This includes strengthening health systems for delivery of prevention, care and treatment services for people living with HIV/AIDS in PEPFAR funded countries and providing management and oversight of international programs aimed at improving quality and innovation in health professions education and training. The division will translate lessons learned from both the Global HIV/AIDS Programs and Special Projects of National Significance projects to the Part A, B, C, D, and F grantee community. In collaboration with the Division of Policy and Data, the division assesses effectiveness of technical assistance efforts/initiatives, identifies new technical assistance needs and priority areas, and participates in the bureau-wide technical assistance workgroup. Section RV–30, Delegations of Authority All delegations of authority and redelegations of authority made to HRSA officials that were in effect immediately prior to this reorganization, and that are consistent with this reorganization, shall continue in effect pending further re-delegation. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 69499 This reorganization is effective upon date of signature. Dated: November 16, 2014. Mary K. Wakefield, Administrator. [FR Doc. 2014–27563 Filed 11–20–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60-Day Comment Request; Application for Collaboration With the Therapeutic Development Branch (TDB), Division of Preclinical Innovation (DPI), National Center for Advancing Translational Sciences (NCATS) Summary: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and for Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Dr. Nora Yang, Therapeutic Development Branch, DPI, NCATS, NIH, 9800 Medical Center Drive, Building B, Rockville, MD 20850, or call non-toll-free number (301) 217– 1077, or Email your request, including your address to: TRND@mail.nih.gov. Formal requests for additional plans and E:\FR\FM\21NON1.SGM 21NON1 69500 Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Application for Collaboration with the Therapeutic Development Branch (TDB), Division of Preclinical Innovation (DPI), National Center for Advancing Translational Sciences (NCATS), 0925–0658, Expiration Date 06/30/2015— EXTENSION, National Center for Advancing Translational Sciences diseases. The TDB uses an application and evaluation process to select collaborators. Selected investigators provide the drug project starting points and ongoing biological/disease expertise throughout the project. The application and evaluation process is necessary to determine amount and quality of current data, select meritorious projects for adoption, and to serve as a basis for determining specific scientific gaps to be filled. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The estimated annualized burden hours are 510. (NCATS), National Institutes of Health (NIH). Need and Use of Information Collection: The Therapeutic Development Branch (TDB) provides opportunities to partner with and gain access to a variety of programs delivering assay development, screening, hit-to-lead chemistry, lead optimization, chemical biology studies, drug development capabilities, expertise, and clinical/regulatory resources in a collaborative environment, with the goal of moving promising therapeutics into human clinical trials for both common and specifically rare and/or neglected ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name TDB Project Information Template .................................................................. Online Collaborator Solicitation (TRND) .......................................................... Online Collaborator Solicitation (BrIDGs) ........................................................ Solicitation Instructions (TRND) ....................................................................... Solicitation Instructions (BrIDGs) ..................................................................... Dated: October 29, 2014. M. Janis Mullaney, Associate Director for Administration, NCATS, NIH. [FR Doc. 2014–27636 Filed 11–20–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES Proposed Collection; 60-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIH) Summary: The National Institutes of Health (NIH), Office of the Director (OD), as part of its continuing effort to reduce paperwork and respondent burden, invites the general public to take this opportunity to comment on the ‘‘Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery ’’ for approval under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501 et. seq.). This collection was developed as part of a Federal Government-wide effort to streamline the process for seeking feedback from the public on service delivery. This notice announces our intent to submit this collection to OMB for approval and solicits comments on specific aspects for the proposed information collection. VerDate Sep<11>2014 18:00 Nov 20, 2014 Jkt 235001 170 100 70 100 70 To Submit Comments and for Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Ms. Mikia P. Currie, Program Analyst, Office of Policy for Extramural Research Administration, 6705 Rockledge Drive, Suite 350, Bethesda, Maryland 20892, or call a non-toll-free number 301–435–0941 or Email your request, including your address to curriem@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIH), 0925–0648, Expiration Date 1/31/2015, EXTENSION, National Institutes of Health (NIH), Office of the Director (OD). Need and Use of Information Collection: We are not requesting changes for this submission. The proposed information collection activity provides a means to garner qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with the Administration’s commitment to improving service delivery. By qualitative feedback we PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 Number of responses per respondent 1 1 1 1 1 Average burden per response (in hours) Total annual burden hour 1 1 1 1 1 170 100 70 100 70 mean information that provides useful insights on perceptions and opinions. This information, however, is not statistical surveys that yield quantitative results, which can be generalized to the population of study. This feedback will provide information about the NIH’s customer or stakeholder perceptions, experiences, and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training, or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative, and actionable communications between the NIH and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. The solicitation of feedback will target areas such as: timeliness, appropriateness, accuracy of information, courtesy, efficiency of service delivery, and resolution of issues with service delivery. Responses will be assessed to plan and inform efforts to improve or maintain the quality of service offered to the public. If this information is not collected, vital feedback from customers and stakeholders on the NIH’s services will be unavailable. The NIH will only submit a collection for approval under this generic clearance if it meets the following conditions: • The collections are voluntary; E:\FR\FM\21NON1.SGM 21NON1

Agencies

[Federal Register Volume 79, Number 225 (Friday, November 21, 2014)]
[Notices]
[Pages 69499-69500]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27636]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request; Application for 
Collaboration With the Therapeutic Development Branch (TDB), Division 
of Preclinical Innovation (DPI), National Center for Advancing 
Translational Sciences (NCATS)

    Summary: In compliance with the requirement of Section 
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity 
for public comment on proposed data collection projects, the National 
Center for Advancing Translational Sciences (NCATS), National 
Institutes of Health (NIH), will publish periodic summaries of proposed 
projects to be submitted to the Office of Management and Budget (OMB) 
for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited on one or more of the following points: (1) 
Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) Ways to enhance the quality, utility, and clarity of the 
information to be collected; and (4) Ways to minimize the burden of the 
collection of information on those who are to respond, including the 
use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.
    To Submit Comments and for Further Information: To obtain a copy of 
the data collection plans and instruments, submit comments in writing, 
or request more information on the proposed project, contact: Dr. Nora 
Yang, Therapeutic Development Branch, DPI, NCATS, NIH, 9800 Medical 
Center Drive, Building B, Rockville, MD 20850, or call non-toll-free 
number (301) 217-1077, or Email your request, including your address 
to: TRND@mail.nih.gov. Formal requests for additional plans and

[[Page 69500]]

instruments must be requested in writing.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: Application for Collaboration with the 
Therapeutic Development Branch (TDB), Division of Preclinical 
Innovation (DPI), National Center for Advancing Translational Sciences 
(NCATS), 0925-0658, Expiration Date 06/30/2015--EXTENSION, National 
Center for Advancing Translational Sciences (NCATS), National 
Institutes of Health (NIH).
    Need and Use of Information Collection: The Therapeutic Development 
Branch (TDB) provides opportunities to partner with and gain access to 
a variety of programs delivering assay development, screening, hit-to-
lead chemistry, lead optimization, chemical biology studies, drug 
development capabilities, expertise, and clinical/regulatory resources 
in a collaborative environment, with the goal of moving promising 
therapeutics into human clinical trials for both common and 
specifically rare and/or neglected diseases. The TDB uses an 
application and evaluation process to select collaborators. Selected 
investigators provide the drug project starting points and ongoing 
biological/disease expertise throughout the project. The application 
and evaluation process is necessary to determine amount and quality of 
current data, select meritorious projects for adoption, and to serve as 
a basis for determining specific scientific gaps to be filled.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The estimated annualized burden 
hours are 510.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
                    Form name                        Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
TDB Project Information Template................             170               1               1             170
Online Collaborator Solicitation (TRND).........             100               1               1             100
Online Collaborator Solicitation (BrIDGs).......              70               1               1              70
Solicitation Instructions (TRND)................             100               1               1             100
Solicitation Instructions (BrIDGs)..............              70               1               1              70
----------------------------------------------------------------------------------------------------------------


    Dated: October 29, 2014.
M. Janis Mullaney,
Associate Director for Administration, NCATS, NIH.
[FR Doc. 2014-27636 Filed 11-20-14; 8:45 am]
BILLING CODE 4140-01-P